{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:04:11Z","timestamp":1782392651540,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education","award":["NRF-2017R1D1A1B03028486"],"award-info":[{"award-number":["NRF-2017R1D1A1B03028486"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s43440-024-00673-7","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T06:06:14Z","timestamp":1730095574000},"page":"247-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of puerarin on gait disturbance in a 6-hydroxydopamine mouse model of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6823-8735","authenticated-orcid":false,"given":"Na-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-6392","authenticated-orcid":false,"given":"Yukiori","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2963-1311","authenticated-orcid":false,"given":"Young-A","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"673_CR1","volume-title":"Parkinson\u2019s Disease: Pathogenesis and clinical aspects","author":"A Kouli","year":"2018","unstructured":"Kouli A, Torsney KM, Kuan WL. Parkinson\u2019s Disease: etiology, neuropathology, and Pathogenesis. In: Stoker TB, Greenland JC, editors. Parkinson\u2019s Disease: Pathogenesis and clinical aspects. Brisbane (AU): Codon; 2018."},{"key":"673_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR. The Parkinson Pandemic-A call to action. JAMA Neurol. 2018;75:9\u201310. https:\/\/doi.org\/10.1001\/jamaneurol.2017.3299.","journal-title":"JAMA Neurol"},{"key":"673_CR3","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1038\/s41598-020-61310-w","volume":"10","author":"MW Ho","year":"2020","unstructured":"Ho MW, Chien SH, Lu MK, Chen JC, Aoh Y, Chen CM, et al. Impairments in face discrimination and emotion recognition are related to aging and cognitive dysfunctions in Parkinson\u2019s disease with dementia. Sci Rep. 2020;10:4367. https:\/\/doi.org\/10.1038\/s41598-020-61310-w.","journal-title":"Sci Rep"},{"key":"673_CR4","doi-asserted-by":"publisher","first-page":"100180","DOI":"10.1016\/j.prdoa.2022.100180","volume":"8","author":"B Lacy","year":"2023","unstructured":"Lacy B, Piotrowski HJ, Dewey RB Jr., Husain MM. Severity of depressive and motor symptoms impacts quality of life in Parkinson\u2019s disease patients at an academic movement clinic: a cross-sectional study. Clin Park Relat Disord. 2023;8:100180. https:\/\/doi.org\/10.1016\/j.prdoa.2022.100180.","journal-title":"Clin Park Relat Disord"},{"key":"673_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3390\/biomedicines9060598","volume":"9","author":"D Masini","year":"2021","unstructured":"Masini D, Plewnia C, Bertho M, Scalbert N, Caggiano V, Fisone G. A guide to the generation of a 6-Hydroxydopamine mouse model of Parkinson\u2019s Disease for the study of non-motor symptoms. Biomedicines. 2021;9:598. https:\/\/doi.org\/10.3390\/biomedicines9060598.","journal-title":"Biomedicines"},{"key":"673_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fnins.2014.00113","volume":"8","author":"S Stayte","year":"2014","unstructured":"Stayte S, Vissel B. Advances in non-dopaminergic treatments for Parkinson\u2019s disease. Front Neurosci. 2014;8:113. https:\/\/doi.org\/10.3389\/fnins.2014.00113.","journal-title":"Front Neurosci"},{"key":"673_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4103\/aian.AIAN_239_17","volume":"20","author":"S Pandey","year":"2017","unstructured":"Pandey S, Srivanitchapoom P. Levodopa-induced Dyskinesia: clinical features, pathophysiology, and Medical Management. Ann Indian Acad Neurol. 2017;20:190\u20138. https:\/\/doi.org\/10.4103\/aian.AIAN_239_17.","journal-title":"Ann Indian Acad Neurol"},{"key":"673_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-020-0116-2","volume":"6","author":"C Gan","year":"2020","unstructured":"Gan C, Wang M, Si Q, Yuan Y, Zhi Y, Wang L, et al. Altered interhemispheric synchrony in Parkinson\u2019s disease patients with levodopa-induced dyskinesias. NPJ Parkinsons Dis. 2020;6:14. https:\/\/doi.org\/10.1038\/s41531-020-0116-2.","journal-title":"NPJ Parkinsons Dis"},{"key":"673_CR9","doi-asserted-by":"publisher","first-page":"19272","DOI":"10.1038\/s41598-023-44142-2","volume":"13","author":"H Asano","year":"2023","unstructured":"Asano H, Tian YS, Hatabu A, Takagi T, Ueda M, Ikeda K. Safety comparisons among monoamine oxidase inhibitors against Parkinson\u2019s disease using FDA adverse event reporting system. Sci Rep. 2023;13:19272. https:\/\/doi.org\/10.1038\/s41598-023-44142-2.","journal-title":"Sci Rep"},{"key":"673_CR10","first-page":"37","volume":"89","author":"JA Borovac","year":"2016","unstructured":"Borovac JA. Side effects of a dopamine agonist therapy for Parkinson\u2019s disease: a mini-review of clinical pharmacology. Yale J Biol Med. 2016;89:37\u201347.","journal-title":"Yale J Biol Med"},{"key":"673_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3233\/JPD-213057","volume":"12","author":"N Kwak","year":"2022","unstructured":"Kwak N, Park J, Kang H-Y, Lee M-J, Suh JK, Lee H. Efficacy and safety of Opicapone for Motor fluctuations as an adjuvant to Levodopa Therapy in patients with Parkinson\u2019s Disease: a systematic review and Meta-analysis. J Parkinson\u2019s Dis. 2022;12:773\u201383. https:\/\/doi.org\/10.3233\/JPD-213057.","journal-title":"J Parkinson\u2019s Dis"},{"key":"673_CR12","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.neuron.2019.03.004","volume":"101","author":"MM McGregor","year":"2019","unstructured":"McGregor MM, Nelson AB. Circuit mechanisms of Parkinson\u2019s Disease. Neuron. 2019;101:1042\u201356. https:\/\/doi.org\/10.1016\/j.neuron.2019.03.004.","journal-title":"Neuron"},{"key":"673_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41401-020-0371-0","volume":"41","author":"HY Chu","year":"2020","unstructured":"Chu HY. Synaptic and cellular plasticity in Parkinson\u2019s disease. Acta Pharmacol Sin. 2020;41:447\u201352. https:\/\/doi.org\/10.1038\/s41401-020-0371-0.","journal-title":"Acta Pharmacol Sin"},{"key":"673_CR14","doi-asserted-by":"publisher","first-page":"105372","DOI":"10.1016\/j.nbd.2021.105372","volume":"155","author":"Z Yin","year":"2021","unstructured":"Yin Z, Zhu G, Zhao B, Bai Y, Jiang Y, Neumann WJ, et al. Local field potentials in Parkinson\u2019s disease: a frequency-based review. Neurobiol Dis. 2021;155:105372. https:\/\/doi.org\/10.1016\/j.nbd.2021.105372.","journal-title":"Neurobiol Dis"},{"key":"673_CR15","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/j.clinph.2006.06.720","volume":"117","author":"JL Bosboom","year":"2006","unstructured":"Bosboom JL, Stoffers D, Stam CJ, van Dijk BW, Verbunt J, Berendse HW, et al. Resting state oscillatory brain dynamics in Parkinson\u2019s disease: an MEG study. Clin Neurophysiol. 2006;117:2521\u201331. https:\/\/doi.org\/10.1016\/j.clinph.2006.06.720.","journal-title":"Clin Neurophysiol"},{"key":"673_CR16","doi-asserted-by":"publisher","first-page":"113513","DOI":"10.1016\/j.expneurol.2020.113513","volume":"335","author":"JK Haumesser","year":"2021","unstructured":"Haumesser JK, Beck MH, Pellegrini F, K\u00fchn J, Neumann WJ, Altsch\u00fcler J, et al. Subthalamic beta oscillations correlate with dopaminergic degeneration in experimental parkinsonism. Exp Neurol. 2021;335:113513. https:\/\/doi.org\/10.1016\/j.expneurol.2020.113513.","journal-title":"Exp Neurol"},{"key":"673_CR17","doi-asserted-by":"publisher","unstructured":"Jackson N, Cole SR, Voytek B, Swann NC. Characteristics of Waveform Shape in Parkinson\u2019s Disease Detected with Scalp Electroencephalography. eNeuro. 2019;6. https:\/\/doi.org\/10.1523\/eneuro.0151-19.2019. ENEURO.0151-19.2019.","DOI":"10.1523\/eneuro.0151-19.2019"},{"key":"673_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/mds.26924","volume":"32","author":"S Alomar","year":"2017","unstructured":"Alomar S, King NK, Tam J, Bari AA, Hamani C, Lozano AM. Speech and language adverse effects after thalamotomy and deep brain stimulation in patients with movement disorders: a meta-analysis. Mov Disord. 2017;32:53\u201363. https:\/\/doi.org\/10.1002\/mds.26924.","journal-title":"Mov Disord"},{"key":"673_CR19","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/joim.13541","volume":"292","author":"M Hariz","year":"2022","unstructured":"Hariz M, Blomstedt P. Deep brain stimulation for Parkinson\u2019s disease. J Intern Med. 2022;292:764\u201378. https:\/\/doi.org\/10.1111\/joim.13541.","journal-title":"J Intern Med"},{"key":"673_CR20","doi-asserted-by":"publisher","first-page":"e2352177","DOI":"10.1001\/jamanetworkopen.2023.52177","volume":"7","author":"ST Jost","year":"2024","unstructured":"Jost ST, Aloui S, Evans J, Ashkan K, Sauerbier A, Rizos A, et al. Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 years: a Nonrandomized Controlled Trial. JAMA Netw Open. 2024;7:e2352177. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.52177.","journal-title":"JAMA Netw Open"},{"key":"673_CR21","doi-asserted-by":"publisher","first-page":"e1109","DOI":"10.1212\/wnl.0000000000007037","volume":"92","author":"WMM Schuepbach","year":"2019","unstructured":"Schuepbach WMM, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, et al. Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology. 2019;92:e1109\u201320. https:\/\/doi.org\/10.1212\/wnl.0000000000007037.","journal-title":"Neurology"},{"key":"673_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/ana.23890","volume":"73","author":"RM deSouza","year":"2013","unstructured":"deSouza RM, Moro E, Lang AE, Schapira AH. Timing of deep brain stimulation in Parkinson disease: a need for reappraisal? Ann Neurol. 2013;73:565\u201375. https:\/\/doi.org\/10.1002\/ana.23890.","journal-title":"Ann Neurol"},{"key":"673_CR23","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.3390\/ijms20184391","volume":"20","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang S, Fu P, Zhang Z, Lin K, Ko JK-S, et al. Roles of glutamate receptors in Parkinson\u2019s Disease. Int J Mol Sci. 2019;20:4391. https:\/\/doi.org\/10.3390\/ijms20184391.","journal-title":"Int J Mol Sci"},{"key":"673_CR24","volume-title":"Parkinson\u2019s Disease: Pathogenesis and clinical aspects","author":"EA Konnova","year":"2018","unstructured":"Konnova EA, Swanberg M. Animal models of Parkinson\u2019s Disease. In: Stoker TB, Greenland JC, editors. Parkinson\u2019s Disease: Pathogenesis and clinical aspects. Brisbane (AU): Codon; 2018."},{"key":"673_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/bf02180027","volume":"96","author":"JM Liebman","year":"1988","unstructured":"Liebman JM, Gerber R, Hall NR, Altar CA. Heterogeneous rotational responsiveness in 6-hydroxydopamine-denervated rats: pharmacological and neurochemical characterization. Psychopharmacology. 1988;96:477\u201383. https:\/\/doi.org\/10.1007\/bf02180027.","journal-title":"Psychopharmacology"},{"key":"673_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0006-8993(70)90187-3","volume":"24","author":"U Ungerstedt","year":"1970","unstructured":"Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970;24:485\u201393. https:\/\/doi.org\/10.1016\/0006-8993(70)90187-3.","journal-title":"Brain Res"},{"key":"673_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fnbeh.2018.00039","volume":"12","author":"J Boix","year":"2018","unstructured":"Boix J, von Hieber D, Connor B. Gait Analysis for Early Detection of Motor Symptoms in the 6-OHDA rat model of Parkinson\u2019s Disease. Front Behav Neurosci. 2018;12:39. https:\/\/doi.org\/10.3389\/fnbeh.2018.00039.","journal-title":"Front Behav Neurosci"},{"key":"673_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0168-9452(03)00077-3","volume":"164","author":"A Kirakosyan","year":"2003","unstructured":"Kirakosyan A, Kaufman PB, Warber S, Bolling S, Chang SC, Duke JA. Quantification of major isoflavonoids and L-canavanine in several organs of kudzu vine (Pueraria montana) and in starch samples derived from kudzu roots. Plant Sci. 2003;164:883\u20138. https:\/\/doi.org\/10.1016\/S0168-9452(03)00077-3.","journal-title":"Plant Sci"},{"key":"673_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3389\/fphar.2017.00599","volume":"8","author":"B Xiao","year":"2017","unstructured":"Xiao B, Sun Z, Cao F, Wang L, Liao Y, Liu X, et al. Brain pharmacokinetics and the Pharmacological effects on Striatal Neurotransmitter Levels of Pueraria lobata isoflavonoids in Rat. Front Pharmacol. 2017;8:599. https:\/\/doi.org\/10.3389\/fphar.2017.00599.","journal-title":"Front Pharmacol"},{"key":"673_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4103\/bc.bc_13_18","volume":"4","author":"S Zhang","year":"2018","unstructured":"Zhang S, Wang J, Zhao H, Luo Y. Effects of three flavonoids from an ancient traditional Chinese medicine Radix puerariae on geriatric diseases. Brain Circ. 2018;4:174\u201384. https:\/\/doi.org\/10.4103\/bc.bc_13_18.","journal-title":"Brain Circ"},{"key":"673_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neuroscience.2014.08.052","volume":"280","author":"X Zhang","year":"2014","unstructured":"Zhang X, Xiong J, Liu S, Wang L, Huang J, Liu L, et al. Puerarin protects dopaminergic neurons in Parkinson\u2019s disease models. Neuroscience. 2014;280:88\u201398. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.08.052.","journal-title":"Neuroscience"},{"key":"673_CR32","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1055\/s-0030-1249976","volume":"76","author":"G Zhu","year":"2010","unstructured":"Zhu G, Wang X, Chen Y, Yang S, Cheng H, Wang N, et al. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson\u2019s disease. Planta Med. 2010;76:1820\u20136. https:\/\/doi.org\/10.1055\/s-0030-1249976.","journal-title":"Planta Med"},{"key":"673_CR33","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.3390\/ijms222111530","volume":"22","author":"B Mendes-Pinheiro","year":"2021","unstructured":"Mendes-Pinheiro B, Soares-Cunha C, Marote A, Loureiro-Campos E, Campos J, Barata-Antunes S, et al. Unilateral Intrastriatal 6-Hydroxydopamine lesion in mice: a closer look into Non-motor phenotype and glial response. Int J Mol Sci. 2021;22:11530. https:\/\/doi.org\/10.3390\/ijms222111530.","journal-title":"Int J Mol Sci"},{"key":"673_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/jnc.15282","volume":"157","author":"SM Zarate","year":"2021","unstructured":"Zarate SM, Pandey G, Chilukuri S, Garcia JA, Cude B, Storey S, et al. Cytisine is neuroprotective in female but not male 6-hydroxydopamine lesioned parkinsonian mice and acts in combination with 17-\u03b2-estradiol to inhibit apoptotic endoplasmic reticulum stress in dopaminergic neurons. J Neurochem. 2021;157:710\u201326. https:\/\/doi.org\/10.1111\/jnc.15282.","journal-title":"J Neurochem"},{"key":"673_CR35","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.bbr.2015.01.053","volume":"284","author":"J Boix","year":"2015","unstructured":"Boix J, Padel T, Paul G. A partial lesion model of Parkinson\u2019s disease in mice\u2013characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res. 2015;284:196\u2013206. https:\/\/doi.org\/10.1016\/j.bbr.2015.01.053.","journal-title":"Behav Brain Res"},{"key":"673_CR36","unstructured":"Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. Academic; 2001."},{"key":"673_CR37","doi-asserted-by":"publisher","first-page":"19478","DOI":"10.1038\/s41598-023-46576-0","volume":"13","author":"A Sl\u00e9zia","year":"2023","unstructured":"Sl\u00e9zia A, Heged\u00fcs P, Rusina E, Lengyel K, Solari N, Kaszas A, et al. Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson\u2019s disease. Sci Rep. 2023;13:19478. https:\/\/doi.org\/10.1038\/s41598-023-46576-0.","journal-title":"Sci Rep"},{"key":"673_CR38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/fbp.0000000000000620","volume":"32","author":"YJ Kim","year":"2021","unstructured":"Kim YJ, Jeon SY, Choi JS, Kim NH, Goto Y, Lee YA. Alterations of amygdala-prefrontal cortical coupling and attention deficit\/hyperactivity disorder-like behaviors induced by neonatal habenula lesion: normalization by Ecklonia stolonifera extract and its active compound fucosterol. Behav Pharmacol. 2021;32:308\u201320. https:\/\/doi.org\/10.1097\/fbp.0000000000000620.","journal-title":"Behav Pharmacol"},{"key":"673_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135. https:\/\/doi.org\/10.1038\/nmeth.2089.","journal-title":"Nat Methods"},{"key":"673_CR40","first-page":"758","volume":"54","author":"B Singh","year":"2016","unstructured":"Singh B, Pandey S, Verma R, Ansari JA, Mahdi AA. Comparative evaluation of extract of Bacopa monnieri and Mucuna pruriens as neuroprotectant in MPTP model of Parkinson\u2019s disease. Indian J Exp Biol. 2016;54:758\u201366.","journal-title":"Indian J Exp Biol"},{"key":"673_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1471-4159.2005.03000.x","volume":"93","author":"M Ahmad","year":"2005","unstructured":"Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, et al. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem. 2005;93:94\u2013104. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03000.x.","journal-title":"J Neurochem"},{"key":"673_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1871524919666190115125900","volume":"19","author":"G Krishna","year":"2019","unstructured":"Krishna G, Hosamani R. Muralidhara. Bacopa monnieri supplements Offset Paraquat-Induced behavioral phenotype and brain oxidative pathways in mice. Cent Nerv Syst Agents Med Chem. 2019;19:57\u201366. https:\/\/doi.org\/10.2174\/1871524919666190115125900.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"673_CR43","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ptr.1486","volume":"18","author":"MS Kim","year":"2004","unstructured":"Kim MS, Lee JI, Lee WY, Kim SE. Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson\u2019s disease. Phytother Res. 2004;18:663\u20136. https:\/\/doi.org\/10.1002\/ptr.1486.","journal-title":"Phytother Res"},{"key":"673_CR44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1460-9568.2008.06314.x","volume":"28","author":"P Rojas","year":"2008","unstructured":"Rojas P, Serrano-Garc\u00eda N, Mares-S\u00e1mano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice: role of oxidative stress. Eur J Neurosci. 2008;28:41\u201350. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06314.x.","journal-title":"Eur J Neurosci"},{"key":"673_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/acm.2009.0342","volume":"16","author":"A Morgan","year":"2010","unstructured":"Morgan A, Stevens J. Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial. J Altern Complement Med. 2010;16:753\u20139. https:\/\/doi.org\/10.1089\/acm.2009.0342.","journal-title":"J Altern Complement Med"},{"key":"673_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/00926239808404927","volume":"24","author":"AJ Cohen","year":"1998","unstructured":"Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther. 1998;24:139\u201343. https:\/\/doi.org\/10.1080\/00926239808404927.","journal-title":"J Sex Marital Ther"},{"key":"673_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2013.05.046","volume":"1523","author":"R Li","year":"2013","unstructured":"Li R, Liang T, Xu L, Zheng N, Zhang K, Duan X. Puerarin attenuates neuronal degeneration in the substantia nigra of 6-OHDA-lesioned rats through regulating BDNF expression and activating the Nrf2\/ARE signaling pathway. Brain Res. 2013;1523:1\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2013.05.046.","journal-title":"Brain Res"},{"key":"673_CR48","doi-asserted-by":"publisher","first-page":"114581","DOI":"10.1016\/j.biopha.2023.114581","volume":"162","author":"X Liu","year":"2023","unstructured":"Liu X, Huang R, Wan J. Puerarin: a potential natural neuroprotective agent for neurological disorders. Biomed Pharmacother. 2023;162:114581. https:\/\/doi.org\/10.1016\/j.biopha.2023.114581.","journal-title":"Biomed Pharmacother"},{"key":"673_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-201x.1971.tb11000.x","volume":"367","author":"U Ungerstedt","year":"1971","unstructured":"Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl. 1971;367:69\u201393. https:\/\/doi.org\/10.1111\/j.1365-201x.1971.tb11000.x.","journal-title":"Acta Physiol Scand Suppl"},{"key":"673_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/s0165-5728(98)00222-7","volume":"93","author":"D Kim","year":"1999","unstructured":"Kim D, Carlson JN, Seegal RF, Lawrence DA. Differential immune responses in mice with left- and right-turning preference. J Neuroimmunol. 1999;93:164\u201371. https:\/\/doi.org\/10.1016\/s0165-5728(98)00222-7.","journal-title":"J Neuroimmunol"},{"key":"673_CR51","doi-asserted-by":"publisher","first-page":"577435","DOI":"10.3389\/fnagi.2020.577435","volume":"12","author":"J Wilson","year":"2020","unstructured":"Wilson J, Alcock L, Yarnall AJ, Lord S, Lawson RA, Morris R, et al. Gait Progression over 6 years in Parkinson\u2019s Disease: effects of Age, Medication, and Pathology. Front Aging Neurosci. 2020;12:577435. https:\/\/doi.org\/10.3389\/fnagi.2020.577435.","journal-title":"Front Aging Neurosci"},{"key":"673_CR52","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1038\/s41598-019-38623-6","volume":"9","author":"L Broom","year":"2019","unstructured":"Broom L, Worley A, Gao F, Hernandez LD, Ashton CE, Shih LC, et al. Translational methods to detect asymmetries in temporal and spatial walking metrics in parkinsonian mouse models and human subjects with Parkinson\u2019s disease. Sci Rep. 2019;9:2437. https:\/\/doi.org\/10.1038\/s41598-019-38623-6.","journal-title":"Sci Rep"},{"key":"673_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbr.2011.03.031","volume":"222","author":"TH Hsieh","year":"2011","unstructured":"Hsieh TH, Chen JJ, Chen LH, Chiang PT, Lee HY. Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion. Behav Brain Res. 2011;222:1\u20139. https:\/\/doi.org\/10.1016\/j.bbr.2011.03.031.","journal-title":"Behav Brain Res"},{"key":"673_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.neuint.2018.11.005","volume":"122","author":"K Miyanishi","year":"2019","unstructured":"Miyanishi K, Choudhury ME, Watanabe M, Kubo M, Nomoto M, Yano H, et al. Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson\u2019s disease model. Neurochem Int. 2019;122:38\u201346. https:\/\/doi.org\/10.1016\/j.neuint.2018.11.005.","journal-title":"Neurochem Int"},{"key":"673_CR55","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.3390\/ijms20184391","volume":"20","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang S, Fu P, Zhang Z, Lin K, Ko JK, et al. Roles of glutamate receptors in Parkinson\u2019s Disease. Int J Mol Sci. 2019;20:4391. https:\/\/doi.org\/10.3390\/ijms20184391.","journal-title":"Int J Mol Sci"},{"key":"673_CR56","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1021\/acschemneuro.6b00354","volume":"8","author":"S Singh","year":"2017","unstructured":"Singh S, Mishra A, Srivastava N, Shukla S. MK-801 (Dizocilpine) regulates multiple steps of adult hippocampal neurogenesis and alters psychological symptoms via Wnt\/\u03b2-Catenin signaling in parkinsonian rats. ACS Chem Neurosci. 2017;8:592\u2013605. https:\/\/doi.org\/10.1021\/acschemneuro.6b00354.","journal-title":"ACS Chem Neurosci"},{"key":"673_CR57","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0006-8993(83)91129-0","volume":"264","author":"TE Robinson","year":"1983","unstructured":"Robinson TE, Becker JB. The rotational behavior model: asymmetry in the effects of unilateral 6-OHDA lesions of the substantia nigra in rats. Brain Res. 1983;264:127\u201331. https:\/\/doi.org\/10.1016\/0006-8993(83)91129-0.","journal-title":"Brain Res"},{"key":"673_CR58","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/brain\/awm034","volume":"130","author":"D Stoffers","year":"2007","unstructured":"Stoffers D, Bosboom JL, Deijen JB, Wolters EC, Berendse HW, Stam CJ. Slowing of oscillatory brain activity is a stable characteristic of Parkinson\u2019s disease without dementia. Brain. 2007;130:1847\u201360. https:\/\/doi.org\/10.1093\/brain\/awm034.","journal-title":"Brain"},{"key":"673_CR59","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41531-022-00350-7","volume":"8","author":"JJ van Rheede","year":"2022","unstructured":"van Rheede JJ, Feldmann LK, Busch JL, Fleming JE, Mathiopoulou V, Denison T, et al. Diurnal modulation of subthalamic beta oscillatory power in Parkinson\u2019s disease patients during deep brain stimulation. NPJ Parkinsons Dis. 2022;8:88. https:\/\/doi.org\/10.1038\/s41531-022-00350-7.","journal-title":"NPJ Parkinsons Dis"},{"key":"673_CR60","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1039\/d0bm01765e","volume":"9","author":"S Xiong","year":"2021","unstructured":"Xiong S, Luo J, Wang Q, Li Z, Li J, Liu Q, et al. Targeted graphene oxide for drug delivery as a therapeutic nanoplatform against Parkinson\u2019s disease. Biomater Sci. 2021;9:1705\u201315. https:\/\/doi.org\/10.1039\/d0bm01765e.","journal-title":"Biomater Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00673-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-024-00673-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-024-00673-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T20:18:08Z","timestamp":1737317888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-024-00673-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1007\/s43440-024-00673-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4738008\/v1","asserted-by":"object"}]},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}